The change we need

Claire’s campaign is calling for the following –

– Changing the narrative around gynaecological cancers. The mismatch between the Welsh Government line about ‘high levels of satisfaction’ and the reality of only 34% of suspected gynaecological cancers meeting the cancer pathway needs to be exposed. Many patients, including Claire have never been asked about their satisfaction levels’.

– A Womens’ Health plan needs to be reviewed to include a specific focus on gynaecological cancers. The newly published ‘Quality Statement for Women and girls’ health’ does not mention gynaecological cancer and will not give the focus needed to ensure improvements.

– The Welsh Government should work with Public Health Wales and organisations to develop a series of campaigns to raise awareness of the symptoms of gynaecological cancers.

– The Welsh Government, in conjunction with the Wales Cancer Network should commission an urgent review of the incidence, trends and high-risk populations in relation to emergency presentations with a gynaecological cancer

The situation facing women in Wales

Every year, there are nearly 1000 cases of gynaecological cancers in Wales.

These cancers are the 4th most common cause of cancer death amongst women here. These include womb (uterus), ovarian, cervical, vulval and vaginal cancers. In addition, women are also diagnosed with gynaecological sarcomas (leiomyosarcoma) that Claire has. These can occur anywhere in the reproductive system, although most gynaecological sarcomas (85%) occur in the uterus (womb) and 7% occur in the ovaries. Wales does not collect data on the number of women diagnosed with leiomyosarcoma, but we do know thatin 2021, 373 women in Wales died from gynaecological cancers. This was made up of 50 cervical cancer deaths, 120 from uterine cancer, and 203 from ovarian cancer. Insight from Tenovus Cancer Care shows that the incidence rate for gynaecological cancer in Wales is higher than the UK average, as is the mortality rate, with sadly 373 women in Wales losing their lives in 2021. In July 2022, only 34% of gynaecological cancers met the Single Cancer Pathway target (for no patients to wait longer than 62 days for treatment). Almost two years later, that figure stands at 32.2%, which shows no progress.

This is a short explanation of the symptoms of each gynaecological cancer.